February 2021: Guyana launches final MDA against LF

After a postponement in 2020 due to Covid-19, Guyana launched its final mass drug administration (MDA) event against lymphatic filariasis in February, aiming to be declared disease-free if the program is successful. The country administered the first dose of the medication in 2017, and will distribute the second dose of ivermectin, diethylcarbamazine, and albendazole (IDA) therapy in regions three and four from February 14-28, followed in March by regions six and ten, followed by other regions. Guyana Department of Public Health Information; Guyana Chronicle